| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 3,423,000 | 2,999,000 | 3,859,000 | 3,148,000 | | Cost of Revenue | 1,872,000 | 3,799,000 | 2,326,000 | 1,045,000 | | | Gross Profit | 1,551,000 | (800,000) | 1,533,000 | 2,103,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,040,000 | (1,368,000) | 947,000 | 1,436,000 | | Non Recurring |
-
|
-
| 34,000 | (295,000) | | Others | 192,000 | 186,000 | 184,000 | 182,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 319,000 | 382,000 | 368,000 | 780,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,000 | 9,000 | 14,000 | 3,000 | | Earnings Before Interest And Taxes | 327,000 | (135,000) | 373,000 | 786,000 | | Interest Expense | 144,000 | 151,000 | 139,000 | 128,000 | | Income Before Tax | 183,000 | (286,000) | 234,000 | 658,000 | | Income Tax Expense | (6,000) | 78,000 | 74,000 | 356,000 | | Minority Interest |
-
| (2,000) | (9,000) | 3,000 | | | | Net Income From Continuing Ops | 183,000 | 160,000 | 160,000 | 302,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 22,000 | 249,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 183,000 | 160,000 | 182,000 | 551,000 | | Preferred Stock And Other Adjustments | (3,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $180,000 | $160,000 | $182,000 | $551,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
